Author: Amanda Ashley, Director of Communications for Research & Innovation, Office of the Vice President for Research The University of Utah has been named to the National Academy of Inventors’ (NAI) 2025 Top 100 U.S. Universities Granted U.S. Utility Patents list, further reinforcing its position as a national leader in research, innovation, and commercialization. This […]
SOUTH JORDAN, Utah, April 01, 2026 (GLOBE NEWSWIRE) — Merit Medical Systems, Inc. (NASDAQ: MMSI), a global leader of healthcare technology, today announced it has acquired View Point Medical, Inc. (View Point). Through a merger transaction, View Point is now a wholly-owned subsidiary of Merit. View Point, located in Carlsbad, California, manufactures the OneMark® Detection […]
First biodistribution study of the Company’s novel targeted lipid nanoparticle achieved systemic circulation with the potential to target many types of cancer Lehi, Utah, March 31, 2026 – CancerVax, Inc., the developer of a breakthrough universal cancer treatment platform that uses the body’s immune system to treat cancer, today announced that the initial biodistribution study […]
TRISCEND II randomized trial data presented at ACC show lower mortality with EVOQUE system, when accounting for patient crossover NEW ORLEANS–(BUSINESS WIRE)– Edwards Lifesciences (NYSE: EW) today announced new data on the EVOQUE transcatheter tricuspid valve replacement (TTVR) system at the American College of Cardiology Annual Scientific Session (ACC.26), demonstrating significant and sustained patient benefits […]
Via OrthoSpineNews Major clinical milestone marks SINTX’s entry into the foot and ankle reconstruction market and advances commercialization of its silicon nitride biomaterial platform SALT LAKE CITY, Utah, March 19, 2026 (GLOBE NEWSWIRE) — SINTX Technologies, Inc. (NASDAQ: SINT) (“SINTX” or the “Company”), a leader in advanced ceramic biomaterials and silicon nitride medical device innovation, […]
Facility in Sudair Industrial City is expected to position CoMira among the early domestic manufacturers of molecular diagnostic testing solutions in Saudi Arabia SALT LAKE CITY, April 2, 2026 /PRNewswire/ — Co-Diagnostics, Inc. (Nasdaq: CODX) (“Co-Dx” or “the Company”), a molecular diagnostics company with a unique, patented platform for the development of molecular diagnostic tests, today announced that CoMira […]
Salt Lake City–based laboratory opens normally restricted space to invited guests, highlighting the behind‑the‑scenes work that helps keep medicines and medical products safe SALT LAKE CITY (April 1, 2026) — Nelson Labs, a Salt Lake City–founded global leader in laboratory testing services, recently hosted invited guests for a rare look inside a new cleanroom […]
Gel embolic device designed to simplify the embolization procedure and reduce risks to the patient.
BioUtah president & CEO, Kelvyn Cullimoire, was invited by the Korean Health Industry Development Institute (KHIDI), an agency of the Korean Ministry of Health, to present at the Medical Korea conference on March 19-20, 2026. The topic of Cullimore’s presentation was “Why Utah is a preferred landing place for Korean medical device companies desiring to […]
BioUtah CEO, Kelvyn Cullimore, Makes the Rounds in DC
First new FDA-approved treatment option in nearly 20 years for families living with this rare lysosomal storage disease.
Biotech is playing an increasingly important role in U.S. economic competitiveness and national security, and Utah plays a key role in contributing to the strength of the American biotech ecosystem.
The addition of APEXecm reflects Kolosis’s continued commitment to developing and commercializing best-in-class solutions for the surgical community
Approval reinforces Myriad’s leadership in comprehensive HRD testing and establishes MyChoice CDx as the only FDA-approved companion diagnostic for Zejula in the U.S.
New Resilience™ deployment system, anti-migration stent design, and unique stent sizes offer physicians control while enhancing treatment for patients with esophageal fistulas and malignant strictures
For Fabry patients, a potential path to converting 130 clinic visits into one treatment every five years.
New results demonstrate early VOXZOGO treatment leads to durable and sustained improvements in skeletal growth-related health outcomes, including proportionality, arm span and body mass index, building on over 10,000 patient-years of data
Lipocine Announces Last Patient Last Visit in Pivotal Phase 3 Trial of LPCN 1154 for Postpartum Depression (PPD)
Women-led companies join Springboard’s accelerator to advance innovation across the women’s health landscape.
Deal complements Medtronic’s Neurovascular portfolio, delivering simplicity and access when ‘time is brain’
The 2026 Wilson Sonsini Entrepreneur & Investor Life Sciences Summit (E&I Summit) served as a launchpad for innovation
ARUP Medical Directors and Genetic Specialists To Showcase Latest Research at ACMG
Launch Represents Significant Step to Broader Commercialization
RDAC Honors Rare Disease Day with RUN, Utah Jazz, Governor Cox
Analytical validation of FirstGene Multiple Prenatal Screen published in Clinical Chemistry
ARUP Creates Innovation Central Laboratory to Accelerate Diagnostic Innovation for Biotechnology and Pharmaceutical Partners
Xenocor Announces FDA Clearance of Saberscope®, the First Single-Use 5mm Articulating Laparoscope for Enhanced Surgical Visualization
SALT LAKE CITY, February 26, 2026— ARUP Laboratories, a leader in diagnostic medicine and the largest nonprofit reference laboratory in the U.S., today announced the launch of a new Innovation Central Laboratory to facilitate collaboration with pharmaceutical, biotechnology, and other industry partners. The Innovation Central Laboratory will serve as an ecosystem for validating technologies and accelerating […]
Twelve rising startups have been selected to present their innovations to investors during the 2026 Entrepreneur & Investor Life Sciences Summit on March 12, sponsored by Wilson Sonsini. Salt Lake City, February 20, 2026—BioUtah, Utah’s trade association dedicated solely to the life sciences, in partnership with Brigham Young University’s (BYU) Technology Transfer Office and College […]
RadSep, Inc., a subsidiary of IBC Advanced Technologies, Inc., provides state-of-the-art purification technology and novel chelators for medical radioisotopes and their precursors (Ac-225, Ra-224, Ra-225, Ra-226, Ra-228, Th-228, Th-232, Pb-212, Cu-67, and more). RadSep offers Molecular Recognition Technology™ (MRT™) resins that are extremely selective, stable and simple to use. First-pass recoveries and purities of 99.9+% […]
CDSCO license on Form MD-5 authorizes CoSara to manufacture PCR Pro instrument in its Ranoli, India facility for sale or distribution
Cytiva Sponsors Operational Excellence Case Study Competition
